Dr. Ogilvie, a professor in the faculty’s School of Population and Public Health, was announced as a renewed Tier 1 Canada Research Chair in Global Control of HPV-Related Disease and Cancer. She is also Senior Public Health Scientist at BC Centre for Disease Control and Senior Research Advisor at the BC Women’s Hospital and Health Centre.
Her research is focused on both the public health and clinical aspects of reproductive health, sexually transmitted infections, HPV screening and the HPV vaccine, and her findings have been highly influential in setting and directing health policy both in Canada and globally. Among other research projects, she is principal investigator for the ASPIRE program.
“I am so delighted that I will be able to continue to focus on this critical work on reducing the burden of STIs and HPV, particularly on the global elimination of cervical cancer,” Dr. Ogilvie said. “I am also so honoured, as a Black female Canadian scientist, to show how scientists from diverse backgrounds can be leaders in their fields, nationally and globally.”
The 15 UBC chairholders represent an investment of $15.1 million through the Canada Research Chairs program. The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced a total investment of more than $102 million, in support of 119 new and renewed Canada Research Chairs at 35 Canadian research institutions.
“Our government recognizes that investing in researchers and scientists results in breakthroughs to advance our society, and benefits all Canadians,” Minister Champagne said in a release. “The Canada Research Chairs Program provides a unique opportunity for researchers to push boundaries and make cutting-edge discoveries with lasting impacts across the health, environment, natural sciences, social sciences and humanities disciplines.”